BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 17633098)

  • 1. [Reactivation of familial hemophagocytic lymphohistiocytosis after non-myeloablative cord blood stem cell transplantation resulted in the early graft failure].
    Yanagimachi M; Goto H; Yokosuka T; Kajiwara R; Kuroki F; Ito S; Yokota S
    Rinsho Ketsueki; 2007 Jun; 48(6):495-500. PubMed ID: 17633098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced-intensity conditioning in unrelated donor cord blood transplantation for familial hemophagocytic lymphohistiocytosis.
    Nishi M; Nishimura R; Suzuki N; Sawada A; Okamura T; Fujita N; Kanai R; Yano J; Adachi S; Yasumi T; Sato E; Yasutomo K; Ishii E; Ohga S
    Am J Hematol; 2012 Jun; 87(6):637-9. PubMed ID: 22488407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
    Strober S
    Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hematopoietic stem cell transplantation for familial hemophagocytic lymphohistiocytosis and Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in Japan.
    Ohga S; Kudo K; Ishii E; Honjo S; Morimoto A; Osugi Y; Sawada A; Inoue M; Tabuchi K; Suzuki N; Ishida Y; Imashuku S; Kato S; Hara T
    Pediatr Blood Cancer; 2010 Feb; 54(2):299-306. PubMed ID: 19827139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful engraftment by second cord blood transplantation with reduced-intensity conditioning after graft rejection due to hemophagocytic syndrome following initial CBT.
    Tanaka H; Ohwada C; Sakaida E; Takeda Y; Abe D; Oda K; Ozawa S; Shimizu N; Masuda S; Cho R; Nishimura M; Saito Y; Nakaseko C
    Bone Marrow Transplant; 2007 Nov; 40(10):995-6. PubMed ID: 17768388
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunosuppressive total lymphoid irradiation-based reconditioning regimens enable engraftment after graft rejection or graft failure in patients treated with allogeneic hematopoietic stem cell transplantation.
    Heinzelmann F; Lang PJ; Ottinger H; Faul C; Bethge W; Handgretinger R; Bamberg M; Belka C
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):523-8. PubMed ID: 17869449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hematopoietic stem cell transplantation in hemophagocytic lymphohistiocytosis: a single-center report of 48 patients.
    Ouachée-Chardin M; Elie C; de Saint Basile G; Le Deist F; Mahlaoui N; Picard C; Neven B; Casanova JL; Tardieu M; Cavazzana-Calvo M; Blanche S; Fischer A
    Pediatrics; 2006 Apr; 117(4):e743-50. PubMed ID: 16549504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cutaneous non-tuberculous mycobacterial infection following cord blood stem cell transplantation].
    Yanagimachi M; Goto H; Yokosuka T; Kajiwara R; Fujii H; Kuroki F; Ito S; Yokota S; Taniguchi A; Shigehira Y; Ikezawa Z; Inayama Y
    Rinsho Ketsueki; 2008 Feb; 49(2):99-103. PubMed ID: 18341040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hematopoietic cell transplantation from an HLA-mismatched familial donor is feasible without ex vivo-T cell depletion after reduced-intensity conditioning with busulfan, fludarabine, and antithymocyte globulin.
    Lee KH; Lee JH; Lee JH; Kim DY; Kim SH; Shin HJ; Lee YS; Kang YA; Seol M; Ryu SG
    Biol Blood Marrow Transplant; 2009 Jan; 15(1):61-72. PubMed ID: 19135944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retransplantation with stem cells from mismatched related donors after graft rejection in pediatric patients.
    Lang P; Mueller I; Greil J; Bader P; Schumm M; Pfeiffer M; Hoelle W; Klingebiel T; Heinzelmann F; Belka C; Schlegel PG; Kremens B; Woessmann W; Handgretinger R
    Blood Cells Mol Dis; 2008; 40(1):33-9. PubMed ID: 17884640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastric antral vascular ectasia in 2-yr-old girl undergoing unrelated cord blood stem cell transplantation.
    Kuroiwa Y; Suzuki N; Mizue N; Hori T; Endo T; Yoshida Y; Tsutsumi H
    Pediatr Transplant; 2005 Dec; 9(6):788-91. PubMed ID: 16269052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unrelated 5/6-locus matched umbilical cord blood transplantation in a 23-month-old child with hemophagocytic lymphohistiocytosis.
    Schwinger W; Urban C; Lackner H; Benesch M; Kerbl R; Dornbusch HJ; Sovinz P; Kögler G
    Bone Marrow Transplant; 1998 Aug; 22(4):393-6. PubMed ID: 9722076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal stem cells remain host-derived independent of the source of the stem-cell graft and conditioning regimen used.
    Bartsch K; Al-Ali H; Reinhardt A; Franke C; Hudecek M; Kamprad M; Tschiedel S; Cross M; Niederwieser D; Gentilini C
    Transplantation; 2009 Jan; 87(2):217-21. PubMed ID: 19155975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy of familial hemophagocytic lymphohistiocytosis with antithymocyte globulins: a single-center retrospective report of 38 patients.
    Mahlaoui N; Ouachée-Chardin M; de Saint Basile G; Neven B; Picard C; Blanche S; Fischer A
    Pediatrics; 2007 Sep; 120(3):e622-8. PubMed ID: 17698967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of Children with Hemophagocytic Lymphohistiocytosis Given Allogeneic Hematopoietic Stem Cell Transplantation in Italy.
    Messina C; Zecca M; Fagioli F; Rovelli A; Giardino S; Merli P; Porta F; Aricò M; Sieni E; Basso G; Ripaldi M; Favre C; Pillon M; Marzollo A; Rabusin M; Cesaro S; Algeri M; Caniglia M; Di Bartolomeo P; Ziino O; Saglio F; Prete A; Locatelli F
    Biol Blood Marrow Transplant; 2018 Jun; 24(6):1223-1231. PubMed ID: 29410181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alemtuzumab, Fludarabine, Low-Dose TBI, and Double Umbilical Cord Transplant for Primary Graft Failure in a Patient with Recurrent HLH.
    Hege K; Quigg T; Delgado D
    Pediatr Blood Cancer; 2016 Feb; 63(2):361-3. PubMed ID: 26488531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic stem cell transplantation from matched related and unrelated donors in thalassemia major patients using a reduced toxicity fludarabine-based regimen.
    Resnick IB; Aker M; Tsirigotis P; Shapira MY; Abdul-Hai A; Bitan M; Gesundheit B; Amar A; Ackerstein A; Samuel S; Slavin S; Or R
    Bone Marrow Transplant; 2007 Nov; 40(10):957-64. PubMed ID: 17846604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allogeneic hemopoietic stem cell transplantation (HSCT) for Wiskott-Aldrich syndrome: a report of the Spanish Working Party for Blood and Marrow Transplantation in Children (GETMON).
    Muñoz A; Olivé T; Martinez A; Bureo E; Maldonado MS; Diaz de Heredia C; Sastre A; Gonzalez-Vicent M;
    Pediatr Hematol Oncol; 2007 Sep; 24(6):393-402. PubMed ID: 17710656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allogeneic hematopoietic stem cell transplantation using a reduced-intensity conditioning regimen in infants: experience at a single institution in Mexico.
    Llano OG; Perez JC; Rodriguez OC; Guerra CM; Aguirre HG; Garza JL; Rodriguez-Romo L; Almaguer DG
    Pediatr Hematol Oncol; 2008; 25(1):39-47. PubMed ID: 18231953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful engraftment of unrelated cord blood stem cells for familial erythrophagocytic lymphohistiocytosis. Kinki Cord Blood Bank.
    Tanaka Y; Hosoi G; Ishii T; Shimoyama T; Fujimura Y; Sako M
    Bone Marrow Transplant; 1998 Sep; 22(5):511-3. PubMed ID: 9733278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.